205 related articles for article (PubMed ID: 18325642)
1. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
Domínguez A; Oviedo M; Carmona G; Batalla J; Bruguera M; Salleras L; Plasència A
Vaccine; 2008 Mar; 26(14):1737-41. PubMed ID: 18325642
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
[TBL] [Abstract][Full Text] [Related]
3. A statistical model to estimate the impact of a hepatitis A vaccination programme.
Oviedo M; Pilar Muñoz M; Domínguez A; Borras E; Carmona G
Vaccine; 2008 Nov; 26(48):6157-64. PubMed ID: 18804511
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis A outbreaks: the effect of a mass vaccination programme.
Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
[TBL] [Abstract][Full Text] [Related]
6. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization.
Domínguez A; Bruguera M; Plans P; Costa J; Salleras L
J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
9. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy].
Bruguera M; Salleras L; Plans P; Vidal J; Navas E; Domínguez A; Batalla J; Taberner JL; Espuñes J
Med Clin (Barc); 1999 Mar; 112(11):406-8. PubMed ID: 10231772
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
Li X; Xu Z; Hofman A
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):93-6. PubMed ID: 10322718
[TBL] [Abstract][Full Text] [Related]
12. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.
Samandari T; Bell BP; Armstrong GL
Vaccine; 2004 Oct; 22(31-32):4342-50. PubMed ID: 15474727
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a mass hepatitis A vaccination program in preadolescents.
Domínguez A; Salleras L; Carmona G; Batalla J
Vaccine; 2003 Jan; 21(7-8):698-701. PubMed ID: 12531343
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility of universal hepatitis A vaccination in Canada.
Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis A disease following the implementation of universal vaccination: who is at risk?
Mor Z; Srur S; Dagan R; Rishpon S
J Viral Hepat; 2010 Apr; 17(4):293-7. PubMed ID: 19691457
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
17. Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the schools of Catalonia (Spain).
Salleras L; Dominguez A; Bruguera M; Cardeñosa N; Batalla J; Carmona G; Navas E; Taberner JL
Vaccine; 2005 Mar; 23(17-18):2181-4. PubMed ID: 15755591
[TBL] [Abstract][Full Text] [Related]
18. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
[TBL] [Abstract][Full Text] [Related]
19. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
[TBL] [Abstract][Full Text] [Related]
20. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.
Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R
Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
